Fenugreek as a Potential Antiviral Agent against Crimean-Congo Hemorrhagic Fever Virus: an In-depth Theoretical Analysis

Fenugreek as a Potential Antiviral Agent Against Crimean-Congo Hemorrhagic Fever Virus

Authors

DOI:

https://doi.org/10.29356/jmcs.v69i4.2384

Keywords:

Fever, diosgenin, tigogenone, vicenin, antiviral

Abstract

Abstract. Fenugreek is widely known for its important medicinal, nutritional, and culinary applications, offering antipyretic, anti-inflammatory, and antiviral effects. Its antiviral properties make it particularly interesting for addressing viruses like Crimean-Congo Hemorrhagic Fever Virus (CCHFV). Given the lack of approved treatments for CCHFV and the virus's high fatality rate, it demands urgent attention. The nucleoprotein of CCHFV, a critical factor in the virus's replication process, has been identified as a promising target for the development of antiviral therapies. This study aimed to discover inhibitors of this protein through virtual screening. A combination of docking studies and molecular dynamics simulations was employed to screen active compounds from fenugreek for their ability to inhibit the nucleoprotein. Given that CCHFV is classified as a biosafety level-4 pathogen by the World Health Organization (WHO), making it difficult to study in conventional laboratories, in-silico methods provide a safe and efficient alternative for identifying potential inhibitors. Based on the results of molecular docking and dynamic simulations, Diosgenin, Tigogenone, and Vicenin-2 are proposed as potential inhibitors of the CCHFV nucleoprotein. These findings suggest that fenugreek constituents could be promising leads in the development of antiviral therapies for CCHFV.

 

Resumen. El fenogreco (Trigonella foenum-graecum) es conocido por sus importantes aplicaciones medicinales, nutricionales y culinarias, ofreciendo efectos antipiréticos, antiinflamatorios y antivirales. Estas últimas lo hacen particularmente interesante para enfrentar virus como el de la Fiebre Hemorrágica de Crimea-Congo (CCHFV, por sus siglas en inglés). Dada la ausencia de tratamientos aprobados para el CCHFV y su alta tasa de mortalidad, se requiere una atención urgente. La nucleoproteína del CCHFV, un factor crítico en el proceso de replicación del virus ha sido identificada como un objetivo prometedor para el desarrollo de terapias antivirales. Este estudio tuvo como objetivo descubrir inhibidores de esta proteína mediante cribado virtual. Se empleó una combinación de estudios de acoplamiento molecular y simulaciones de dinámica molecular para evaluar la capacidad de compuestos activos del fenogreco para inhibir la referida nucleoproteína. Dado que el CCHFV está clasificado por la Organización Mundial de la Salud (OMS) como un patógeno de nivel de bioseguridad 4, se dificulta su estudio en laboratorios convencionales, por lo que los métodos in silico ofrecen una alternativa segura y eficiente para la identificación de posibles inhibidores. Con base en los resultados del acoplamiento molecular y las simulaciones dinámicas, se proponen a la diosgenina, la tigogenona y la vicenina-2 como posibles inhibidores de la nucleoproteína del CCHFV. Estos hallazgos sugieren que los componentes del fenogreco podrían constituir candidatos prometedores en el desarrollo de terapias antivirales contra el CCHFV.

Downloads

Download data is not yet available.

Author Biographies

Sumit Kumar, Magadh University

PG Department of Chemistry

Ravindra Kumar, Magadh University

PG Department of Chemistry

Nagendra Kumar, Magadh University

PG Department of Chemistry

References

1. Srinivasan, K. Food Rev. Int. 2006 22, 203. DOI: http://dx.doi.org/10.1080/87559120600586315. DOI: https://doi.org/10.1080/87559120600586315

2. Al‐Habori, M.; Raman, A., in: Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 1998 12, 233 DOI: https://doi.org/10.1002/(SICI)1099-1573(199806)12:4<233::AID-PTR294>3.0.CO;2-V

3. Smith, M. Alternative Medicine Review. 2003 8, 20 DOI: https://doi.org/10.1044/leader.FTR2.08202003.6

4. Sun, W.; Shahrajabian, M. H.; Cheng, Q. Mini Rev. Med. Chem. 2021 21, 724. DOI: http://dx.doi.org/10.2174/1389557520666201127104907. DOI: https://doi.org/10.2174/1389557520666201127104907

5. Singletary, K. W. Nutr. Today. 2017, 52, 93. DOI: https://doi.org/10.1097/NT.0000000000000209

6. Aboubakr, H. A.; Nauertz, A.; Luong, N. T.; Agrawal, S.; El-Sohaimy, S. A.; Youssef, M. M.; Goyal, S. M. J. Food Prot. 2016, 79, 1001. DOI: http://dx.doi.org/10.4315/0362-028X.JFP-15-593. DOI: https://doi.org/10.4315/0362-028X.JFP-15-593

7. Alu'datt, M. H.; Rababah, T.; Al‐ali, S.; Tranchant, C. C.; Gammoh, S.; Alrosan, M.; Kubow, S.; Tan, T. C.; Ghatasheh, S. J. Food Sci. 2024, 89, 1835 DOI: https://doi.org/10.1111/1750-3841.16970

8. Salam, S. G. A.; Rashed, M. M.; Ibrahim, N. A.; Rahim, E. A. A.; Aly, T. A. A.; Al-Farga, A. Sci. Rep. 2023, 13, 7032. DOI: http://dx.doi.org/10.1038/s41598-023-31888-y. DOI: https://doi.org/10.1038/s41598-023-31888-y

9. Haxhiraj, M.; White, K.; Terry, C. Int. J. Mol. Sci. 2024, 25, 6987. DOI: http://dx.doi.org/10.3390/ijms25136987. DOI: https://doi.org/10.3390/ijms25136987

10. Agrawal, S.; Sanap, S. N.; Bisen, A. C.; Biswas, A.; Choudhury, A. D.; Verma, S. K.; Jaiswal, S.; Narender, T.; Bhatta, R. S. Bioanalysis. 2023, 15, 711. DOI: http://dx.doi.org/10.4155/bio-2023-0074. DOI: https://doi.org/10.4155/bio-2023-0074

11. Ahmad, I.; Kuznetsov, A. E.; Pirzada, A. S.; Alsharif, K. F.; Daglia, M.; Khan, H. Front. Chem. 2023, 11, 1145974. DOI: http://dx.doi.org/10.3389/fchem.2023.1145974. DOI: https://doi.org/10.3389/fchem.2023.1145974

12. Konstantinidis, N.; Franke, H.; Schwarz, S.; Lachenmeier, D. W. Molecules. 2023, 28, 3460. DOI: http://dx.doi.org/10.3390/molecules28083460. DOI: https://doi.org/10.3390/molecules28083460

13. Arya, P.; Munshi, M.; Kumar, P. Food Chemistry Advances. 2023, 2, 100170. DOI: https://doi.org/10.1016/j.focha.2022.100170

14. Aghababaei, F.; Hadidi, M. Pharmaceuticals. 2023, 16, 1020. DOI: http://dx.doi.org/10.3390/ph16071020. DOI: https://doi.org/10.3390/ph16071020

15. Whitehouse, C. A. Antiviral Res. 2004, 64, 145. DOI: http://dx.doi.org/10.1016/j.antiviral.2004.08.001. DOI: https://doi.org/10.1016/j.antiviral.2004.08.001

16. Elaldi, N.; and Kaya, S. J. Med. Microbiol. Infect. Dis. 2014, 4, 1. DOI: https://doi.org/10.5799/ahinjs.02.2014.S1.0135

17. Swanepoel, R.; Gill, D. E.; Shepherd, A. J.; Leman, P. A.; Mynhardt, J. H.; Harvey, S. Rev. Infect. Dis. 1989, 11, Suppl 4, S794. DOI: http://dx.doi.org/10.1093/clinids/11.supplement_4.s794. DOI: https://doi.org/10.1093/clinids/11.Supplement_4.S794

18. Deyde, V. M.; Khristova, M. L.; Rollin, P. E.; Ksiazek, T. G.; Nichol, S. T. J. Virol. 2006, 80, 8834. DOI: http://dx.doi.org/10.1128/JVI.00752-06. DOI: https://doi.org/10.1128/JVI.00752-06

19. Kumar Panja, S.; Kumar, S.; Fazal, A. D.; Bera, S. J. Photochem. Photobiol. A Chem. 2023, 445, 115084. DOI: http://dx.doi.org/10.1016/j.jphotochem.2023.115084. DOI: https://doi.org/10.1016/j.jphotochem.2023.115084

20. Kumar Panja, S.; and Kumar, S. J. Mol. Liq. 2023, 375, 121354. DOI: http://dx.doi.org/10.1016/j.molliq.2023.121354. DOI: https://doi.org/10.1016/j.molliq.2023.121354

21. Kumar, S.; Prajapat, A.; Panja, S. K.; Shukla, M., in: Green Chemical Synthesis with Microwaves and Ultrasound. 2024, 1. DOI: https://doi.org/10.1002/9783527844494.ch1

22. Kumar Sada, P.; Kaur Jassal, A.; Bar, A.; Kumar, P.; Srikrishna, S.; Kumar, S.; Kumar Singh, A.; Lee, Y.; Singh, L.; Rai, A. Microchem. J. 2024, 207, 111710. DOI: http://dx.doi.org/10.1016/j.microc.2024.111710. DOI: https://doi.org/10.1016/j.microc.2024.111710

23. Panja, S. K.; Kumar, S.; Haddad, B.; Patel, A. R.; Villemin, D.; Amine, H.-M.; Bera, S.; Debdab, M. Physchem. 2024, 4, 369. DOI: http://dx.doi.org/10.3390/physchem4040026. DOI: https://doi.org/10.3390/physchem4040026

24. Srivastava, S.; Kumar, S.; Sharma, P. K.; Rustagi, S.; Mohanty, A.; Donovan, S.; Henao-Martinez, A. F.; Sah, R.; Franco-Paredes, C. Health Sci. Rep. 2024, 7, e70053. DOI: http://dx.doi.org/10.1002/hsr2.70053. DOI: https://doi.org/10.1002/hsr2.70053

25. Kiefer, F.; Arnold, K.; Kunzli, M.; Bordoli, L.; Schwede, T. Nucleic Acids Res. 2009 37, D387. DOI: http://dx.doi.org/10.1093/nar/gkn750. DOI: https://doi.org/10.1093/nar/gkn750

26. Waterhouse, A.; Bertoni, M.; Bienert, S.; Studer, G.; Tauriello, G.; Gumienny, R.; Heer, F. T.; de Beer, T. A. P.; Rempfer, C.; Bordoli, L.; Lepore, R.; Schwede, T. Nucleic Acids Res. 2018, 46, W296. DOI: http://dx.doi.org/10.1093/nar/gky427. DOI: https://doi.org/10.1093/nar/gky427

27. Madeira, F.; Madhusoodanan, N.; Lee, J.; Eusebi, A.; Niewielska, A.; Tivey, A. R. N.; Lopez, R.; Butcher, S. Nucleic Acids Res. 2024, 52, W521. DOI: http://dx.doi.org/10.1093/nar/gkae241. DOI: https://doi.org/10.1093/nar/gkae241

28. Muhamad, F.; Ahmad, R. B.; Asi, S.; Murad, M. N. J. Phys. Conf. Ser. 2018, 1019, 012085. DOI: https://doi.org/10.1088/1742-6596/1019/1/012085

29. Kumar, S., J. Serb. Chem. Soc. 2023 88, 381 DOI: http://dx.doi.org/10.2298/jsc220921087k. DOI: https://doi.org/10.2298/JSC220921087K

30. Kumar, S.; and Panja, S. K. Theor. Chem. Acc. 2023, 142, 126. DOI: http://dx.doi.org/10.1007/s00214-023-03073-x. DOI: https://doi.org/10.1007/s00214-023-03073-x

31. Trott, O.; and Olson, A. J. J. Comput. Chem. 2010, 31, 455. DOI: http://dx.doi.org/10.1002/jcc.21334. DOI: https://doi.org/10.1002/jcc.21334

32. Berendsen, H. J.; van der Spoel, D.; van Drunen, R. Comput. Phys. Commun. 1995, 91, 43. DOI: https://doi.org/10.1016/0010-4655(95)00042-E

33. Mark, P.; and Nilsson, L. J. Phys. Chem. A. 2001, 105, 9954. DOI: https://doi.org/10.1021/jp003020w

34. Kumar, V.; Kumar, R.; Kumar, N.; Kumar, S. Asian J. Chem. 2023, 35, 991. DOI: http://dx.doi.org/10.14233/ajchem.2023.27594. DOI: https://doi.org/10.14233/ajchem.2023.27594

35. Ergonul, O. Curr. Opin. Virol. 2012, 2, 215. DOI: http://dx.doi.org/10.1016/j.coviro.2012.03.001. DOI: https://doi.org/10.1016/j.coviro.2012.03.001

36. Frank, M. G.; Weaver, G.; Raabe, V. Emerg. Infect. Dis. 2024, 30, 847. DOI: http://dx.doi.org/10.3201/eid3005.231646. DOI: https://doi.org/10.3201/eid3005.231646

37. Tewari, A.; Singh, R.; Brar, J. K. J. Phytopharm. 2024, 13, 97. DOI: http://dx.doi.org/10.1016/j.sajb.2022.04.014. DOI: https://doi.org/10.1016/j.sajb.2022.04.014

38. Contreras-Garcia, J.; Johnson, E. R.; Keinan, S.; Chaudret, R.; Piquemal, J. P.; Beratan, D. N.; Yang, W. J. Chem. Theory Comput. 2011, 7, 625. DOI: http://dx.doi.org/10.1021/ct100641a. DOI: https://doi.org/10.1021/ct100641a

×

Downloads

Additional Files

Published

2025-10-01

Issue

Section

Regular Articles
x

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.

Loading...